Methodological and Clinical Aspects of Cyclosporin Monitoring: Report of the Association of Clinical Biochemists Task Force

Shaw LM Bowers L Demers L Freeman D Moyer T Sanghvi A Critical issues in cyclosporine monitoring: Report of the task force on cyclosporine monitoring. Clin Chem 1987; 33: 1269–88.

Kahan BD Shaw LM Holt DW Grevel J Johnston A . Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 1990; 36: 1510–16.

Shaw LM Yatscoff RW Bowers LD Freeman DJ Jeffery JR Keown PA Canadian consensus meeting on cyclosporine monitoring: Report of the consensus panel. Clin Chem 1990; 36: 1841–6.

Kahan BD . Cyclosporin. N Engl J Med 1989; 321: 1725–38.

Fahr A . Cyclosporin (Sandimmun®): Clinical pharmacokinetics. Clin Pharmacokinet 1993; 24: 472–95.

Bleck JS Nashan B Christians U Schottmann R Wonigeit K Sewing K-F . Single dose pharmacokinetics of ciclosporin and its main metabolites after oral ciclosporin as oily solution or capsule. Arzneimittelforschung 1990; 40: 62–4.

Tewari A Ward RG Sells RA Roberts NB . Reduced bioavailability of cyclosporin A capsules in a renal transplant patient with partial gastrectomy and ileal resection. Ann Clin Biochem 1993; 30: 587–9.

Lindholm A Kahan BD . Influence of cyclosporine pharmacokinetics, trough concentrations and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993; 54: 205–18.

Ptachcinski RJ Venkataramanan R Burckart GJ . Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet 1986; 11: 107–32.

Cakaloglu Y Marinos G Marsden J Peters TJ Williams R Tredger JM . Localization of cyclosporin A absorption in rat small bowel and the effect of bile. Clin Sci 1993; 84: 675–9.

Drewe J Beglinger C Kissel T . The absorption of cyclosporine in the human gastrointestinal tract. Br J Clin Pharmacol 1992; 33: 39–43.

Drewe J Meier R Vonderscher J Kiss D Posanski U Kissel T Enchancement of the oral absorption of cyclosporin in man. Br J Clin Pharmacol 1992; 34: 60–4.

Trull AK Tan KKC Uttridge J Bauer T Alexander GJM Jamieson NW . Cyclosporin absorption from microemulsion formulation in liver transplant recipient. Lancet 1993; 341: 433.

Lindholm A Dahlqvist R Groth GG Sjoqvist F . A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation. Br J Clin Pharmacol 1990; 30: 443–52.

Moyer TP Post GR Sterioff S Anderson CF . Cyclosporine nephrotoxicity is minimised by adjusting dosage on the basis of drug concentration in blood. Mayo Clin Proc 1988; 63: 241–7.

Holt DW Marsden JT Johnston A Taube DH . Cyclosporine monitoring with polyclonal and specific monoclonal antibodies during episodes of renal allograft dysfunction. Transplant Proc 1989; 21: 1482–4.

Trull AK Hue K Tan K Gore S Whitewood S Smyth R Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients. Clin Chem 1990; 36: 1474–8.

Gurecki J Warty V Sanghvi A . The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients. Transplant Proc 1985; 17: 1997–2002.

Awni WM Heim-Duthoy K Kasiske BL . Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients. Transplant Proc 1990; 22: 1193–6.

Lindholm A Henricsson S Gang P . The free fraction of cyclosporine in plasma: Clinical findings with a new method. Transplant Proc 1988; 20(suppl 2): 377–81.

Kahan BD Grevel J . Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 1988; 46: 631–44.

Kronbach T Fischer V Meyer UA . Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43: 630–5.

Combalert J Fabre I Dalet I Derancourt J Cano JP Maurel P . Metabolism of cyclosporin A. IV. Purification and identification of the rifampicin-inducible human liver cytochrome P450 (cyclosporin A oxidase) as a product of the P450IIIA gene family. Drug Metab Dispos 1989; 17: 197–207.

Aoyama T Yamano S Waxman DJ Lapenson DP Meyer UA Fischer V Cytochrome P-450 hPCN3, a novel cytochrome P-450 III A gene product that is differentially expressed in adult human liver. J Biol Chem 1989; 264: 1388–95.

Gonzalez FJ . Human cytochromes P450: Problems and prospects. Trends Pharmacol Sci 1992; 13: 346–52.

Bertault-Peres P Bonfils C Fabre G Just S Cano JP Maurel P . Metabolism of cyclosporine A II. Implication of the macrolide antibiotic inducible cytochrome P-450 3c from rat liver microsomes. Drug Metab Dispos 1987; 15: 391–8.

Yatscoff RW Rosano TG Bowers LD . The clinical significance of cyclosporine metabolites. Clin Biochem 1991; 24: 23–35.

Yee GC McGuire TR . Pharmacokinetic drug interactions with cyclosporin. Part 1. Clin Pharmacokinet 1990; 19: 319–32.

Yee GC McGuire TR . Pharmacokinetic drug interactions with cyclosporin. Part 2. Clin Pharmacokinet 1990; 19: 400–15.

Hoppu K Koskimies O Holmberg C Hirvisalo EL . Evidence for pre-hepatic metabolism of oral cyclosporine in children. Br J Clin Pharmacol 1991; 32: 477–81.

Kolars JC Awni WM Merion RM Watkins PB . First-pass metabolism of cyclosporin by the gut. Lancet 1991; 338: 1488–9.

Gupta SK Bakran A Johnson RWG Rowland M . Cyclosporin-erythromycin interaction in renal transplant patients. Br J Clin Pharmacol 1989; 27: 275–81.

First MR Weistkittel P Alexander JW Schroeder TJ Myre SA Pesce AJ . Concomitant administration of cyclosporin and ketoconazole in renal transplant recipients. Lancet 1989; ii: 1198–201.

Butman SM Wild JC Nolan PE Fagan TC Finley PR Hicks MJ Prospective study of the safety and financial benefit of ketoconazole as adjunctive therapy to cyclosporine after heart transplantation. J Heart Lung Transplant 1991; 10: 351–8.

First MR Schroeder TJ Michael A Hariharan S Weiskittel P Alexander JW . Cyclosporineketoconazole interaction: Long-term follow-up and preliminary results of a randomized trial. Transplantation 1991; 55: 1000–4.

Holt DW Johnston A . Cyclosporin and vitamin E. Lancet 1991; 338: 697.

Lindholm A . Factors influencing the pharmacokinetics of cyclosporine in man. Ther Drug Monit 1991; 13: 465–77.

Burckart G Starzl T Williams L Sanghvi A Gartner C Venkataramanan R Cyclosporin monitoring and pharmacokinetics in paediatric liver transplant patients. Transplant Proc 1985; 17: 1172–5.

Ptachcinski RJ Burckart GJ Rosenthal JT Venkataramanan R Howrie DL Taylor FJ Cyclosporine pharmacokinetics in children following a cadaveric renal transplantation. Transplant Proc 1986; 18: 766–7.

Yee GC Lennon TP Gmur DJ Kennedy MS Deed HJ . Age-dependent cyclosporine pharmacokinetics in marrow transplant recipients. Clin Pharmacol Ther 1986; 40: 438–43.

Zeevi A Venkataramanan R Burckart G Wang CP Murase N Van Thiel DH Sensitivity of activated human lymphocytes to cyclosporine and its metabolites. Human Immunol 1988; 21: 143–53.

Rosano T Freed B Cerill J . Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients. Transplantation 1986; 42: 262–7.

Copeland KR Yatscoff RW McKenna RM . Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance. Clin Chem 1990; 36: 225–9.

Wonigeit K Kohlhaw K Winkler M Schaefer O Pichlmayr R . Cyclosporin monitoring in liver allograft recipients: Two distinct patterns of blood level derangement associated with nephrotoxicity. Transplant Proc 1990; 22: 1305–11.

Christians U Kohlhaw K Budniak J Bleck JS Schottmann R Schlitt HJ Ciclosporin metabolite pattern in blood and urine of liver graft recipients. I. Association of ciclosporin metabolites with nephrotoxicity. Eur J Clin Pharmacol 1991; 41: 285–90.

Bleck JS Schlitt HJ Schottmann R Schottmann R Thiesemann C Kohlhaw K Ciclosporin metabolite pattern in blood and urine of kidney graft patients in relation to liver function. Eur J Clin Pharmacol 1991; 40: 565–9.

Donatsch P Rickenbacher U Ryffel B Brouillard J-F . Sandimmun metabolites: Their potential to cause adverse reactions in the rat. Transplant Proc 1990; 22: 1137–40.

Niederberger W Schaub P Beveridge T . High-performance liquid chromatographic determination of cyclosporin A in plasma and urine. J Chromatogr 1980; 182: 454–8.

Rocher LL Giacher QD Annesley T . Refinement in HPLC analysis for cyclosporin: Comparison of two alkyl chain columns. Transplant Proc 1986; 18: 454–8.

Maguire S Kyne F UaConaill D . Specimen collection in plastic containers gives rise to interferents in liquid chromatographic assays of cyclosporin. Clin Chem 1987; 33: 1493–4.

Oosthuizen MMJ Jacobs DR Myburgh JA . Preparation, extraction and high-performance liquid chromatography of cyclosporin A from plasma that contains interfering compounds. Ann Clin Biochem 1985; 22: 402–7.

Sawchuck RJ Cartier LL . Liquid-chromatographic determination of cyclosporin A in blood and plasma. Clin Chem 1981; 27: 1368–71.

Annesley T Matz K Balogh L Clayton L Giacherio D . Liquid-chromatographic analysis of cyclosporin with use of a microbore column and small sample volume. Clin Chem 1986; 32: 1407–9.

Kahn GC Shaw LM Kane MD . Routine monitoring of cyclosporin in whole blood and in kidney tissue using high performance liquid chromatography. J Anal Toxicol 1986; 10: 28–34.

Shah AK Sawchuck RJ . Improved liquid-chromatography determination of cyclosporin and its metabolites in blood. Clin Chem 1988; 34: 1467–71.

Fletcher SJ Bacchus RA . A simple improved method for the measurement of cyclosporin by liquid-liquid extraction of whole blood and isocratic HPLC. Ann Clin Biochem 1988; 25: 510–5.

Allwood CM Lawrance R . High pressure liquid chromatographic determination of cyclosporin A in plasma. J Clin Hosp Pharm 1981; 6: 195–9.

Moyer TP Johnson P Fraynor SM Sterioff S . Cyclosporin: A review of drug monitoring problems and presentation of a simple, accurate liquid chromatographic procedure that solves these problems. Clin Biochem 1986; 19: 83–9.

Lensmeyer G Fields B . Improved liquid-chromatographic determination of cyclosporin with concomitant detection of a cell bound metabolite. Clin Chem 1985; 31: 196–201.

Lensmeyer GL Wiebe DA Carlson IH . Identification and analysis of nine metabolites of cyclosporin in whole blood by liquid chromatography 1: Purification of analytical standards and optimisation of the assay. Clin Chem 1988; 33: 1841–50.

Varghese Z Chan MK Steele LV Sweny P Fernando ON Moorhead JF How to measure cyclosporin. Lancet 1984; i: 1407–8.

Maguire S Kyne F Uaconaille D . An improved extraction procedure for an HPLC method for cyclosporin A in whole blood and plasma. Ann Clin Biochem 1987; 24: 161–6.

Roberts NB Lane C Scott MH Sells RA . The measurement of cyclosporin A metabolite M17 in whole blood by high performance liquid chromatography. Transplant Proc 1988; 20(suppl 2): 625–32.

Wilms HWF Lison AE . Fast and specific measurement of cyclosporin A blood levels: A reliable high-performance liquid chromatography method. Transplant Proc 1988; 20(suppl 2): 357–60.

Hamilton G Roth E Wallisch E Tichy F . Monitoring cyclosporin A in whole blood. HPLC sample purification and separation using column-switching techniques. Chromatography 1985; 6: 2–3.

Smith HT Robinson WT . Semi-automated high-performance liquid chromatographic method for the determination of cyclosporin in plasma and blood using column switching. J Chromatogr 1984; 305: 353–62.

Nussbaumer K Niederberger W Keller HP . Determination of cyclosporin A in blood and plasma by column switching HPLC after rapid sample preparation. J High Resol Chromatogr Comm 1982; 5: 424–7.

Resenthaler J Keller HP . Comment on cyclosporine assay techniques: An attempt for recommendations. Transplant Proc 1990; 22: 1160–5.

Yee GC Gomer DJ Meier P . Measurement of blood cyclosporin metabolite concentrations with a new column-switching high performance liquid chromatographic assay. Transplant Proc 1988; 20(suppl 2): 585–90.

Wallemacq PE Lesne M . A new automated HPLC analysis of cyclosporin A and G in human serum. J Chromatogr 1987; 413: 131–40.

Lachno DR Patel N Rose ML Yacoub MH . Improved high-performance liquid chromatographic method for analysis of cyclosporin A using an automated sample processor. J Chromatogr (Biomed Applic) 1990; 525: 123–32.

Fois RA Ashley JJ . Synthesis of a fluorescent derivative of cyclosporin A for high-performance liquid chromatographic analysis. J Pharm Sci 1991; 80: 363–7.

Uchida K Yamada N Orihara Y Tominaga Y Tanaka Y Hayashi S Minimal low dosage of cyclosporin therapy in renal transplantation by careful monitoring of high-performance liquid chromatography whole blood trough levels. Transplant Proc 1988; 20(suppl 2): 394–401.

Carruthers SG Freeman DJ Koegler JC Howson W Keown PA Laupacis A Simplified liquid-chromatographic analysis for cyclosporin A and comparison with radioimmunoassay. Clin Chem 1983; 29: 180–3.

Kabra PM Wall JH Blanchaest N . Solid-phase extraction and liquid chromatography for improved assay of cyclosporin in whole blood or plasma. Clin Chem 1985; 31: 1717–20.

Turnell DC Cooper JDH . Automated sequential process for preparing samples for analysis by high-performance liquid chromatography. J Chromatogr 1987; 395: 613–21.

Lensmeyer GL Wiebe DA Carlson IH . Deposition of nine metabolites of cyclosporin in human tissues, bile, urine and whole blood. Transplant Proc 1988; 20: 614–22.

Freed BM Stevens C Zhang G Rosano TG Lernpert N . A comparison of the effects of cyclosporin and steroids on human T lymphocyte responses. Transplant Proc 1988; 20: 233–9.

Rosano TG Pell MA Freed BM Dybas MT Lempert N . Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection or good renal function: Comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Transplant Proc 1988; 20(suppl 2): 330–8.

Wang CP Burckart GJ Venkataramanan R . Separation of cyclosporin metabolites: Evaluation of high pressure liquid chromatographic column performance. Ther Drug Monit 1988; 10: 306–9.

Christians U Zimmer K-O Wonigeit K Maurer G Sewing K-Fr Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile and urine. Clin Chem 1988; 34: 34–9.

Johnston A Holt DW . External quality assessment scheme for cyclosporin. Scand J Clin Lab Invest Suppl 1993; 53(212): 48–53.

Quesniaux V Tees R Schrier MH Maurer G van Regenmortel MHV . Potential of monoclonal antibodies to improve therapeutic monitoring of cyclosporin. Clin Chem 1987; 33: 32–7.

Lensmeyer G de Vos D Horswill J Rohde DA Carlson IH Wiebe DA . Cross reactivity study of cyclosporin metabolites with the commercial whole blood immunoassays. Clin Chem 1988; 34: 1269.

Clerico A Zucchelli GC Pilo A Pellegrini M Gazzetti P . Results of a national collaborative study for the analytical evaluation of cyclosporin immunoassay. Clin Chem 1991; 37: 957.

Holt DW Marsden JT Johnston A . Quality assessment of cyclosporin measurements: Comparison of current methods. Transplant Proc 1990; 22: 1234–9.

Tredger JM Steward CM Williams R . Cyclosporin blood levels—an evaluation of radioimmunoassay with selective monoclonal or polyclonal antibodies and high performance liquid chromatography in liver transplant recipients. Transplantation 1988; 46: 681–6.

Hansen JB Lau HP Janes CJ Lehane DP Miller WK . A rapid and specific assay for the du Pont aca discrete clinical analyzer performed directly on whole blood. Transplant Proc 1990; 22: 1189–92.

Johnston A Marsden JT Holt DW . Sample pretreatment to minimize interference from whole blood in the radioimmunoassay for cyclosporine. Transplantation 1987; 44: 332.

Holt DW Marsden JT Fashola TOA Johnston A . Performance of the Sandoz radioimmunoassays for cyclosporin. Transplant Proc 1990; 22: 1155–9.

Johnston A Marsden JT Holt DW . The continuing need for quality assessment of cyclosporin measurement. Clin Chem 1989; 35: 1309–12.

Lee SC Brudzinski AM Yaswineli JL Johanson NJ Ferber IA Maas LK Measurement of cyclosporin A by a specific radioimmunoassay with a monoclonal antibody and ¹²⁵I tracer. Clin Biochem 1991; 24: 43–8.

Blick KE Melouk SH Fry HD Gillum RL . A validation study of selected methods routinely used for measurement of cyclosporin. Clin Chem 1990; 36: 670–4.

Wong PY Ma J . Specific and non-specific ¹²⁵I-Incstar assays. Transplant Proc 1990; 22: 1166–70.

Tredger JM Gonde CE Williams R . Monitoring cyclosporin in liver transplant recipients: Effects of clinical status on the performance of two monoclonal antibody-based methods. Clin Chem 1992; 38: 108–13.

Wallemacq PE Lee SC Lhoëst G Hassoun A . Cross-reactivity of cyclosporin metabolites in two different radioimmunoassays in which the same specific antibody is used. Clin Chem 1990; 36: 385.

Copeland KR Yatscoff RW . Calibration problems with the ¹²⁵I immunoassay for measuring cyclosporin A. Clin Chem 1989; 35: 1551–2.

McBride JH Rodgerson SS Reyes AF . Measurement of cyclosporin in plasma from patients with various transplants: HPLC and radioimmunoassay with a specific monoclonal antibody compared. Clin Chem 1989; 35: 1726–30.

Keown PA Glenn J Denegri J Maciejewska U Seccombe D Stawecki M Therapeutic monitoring of cyclosporin: Impact of a change in standards on ¹²⁵I monoclonal RIA performance in comparison with liquid chromatography. Clin Chem 1990; 36: 804–7.

Holt DW Johnston A . HPLC and CYCLO-Trac SP radioimmunoassay compared for monitoring cyclosporine. Clin Chem 1992; 38: 442–3.

Johnston A Holt DW . Calibration of the CYCLO-Trac SP cyclosporine radioimmunoassay. Clin Chem 1993; 39: 2532–3.

Tredger JM Gonde CE Williams R . Monitoring cyclosporine in liver transplant recipients. Clin Chem 1993; 39: 164–5.

Wang P Meucci V Simpson E Morrison M Lunetta S Zajac M Monoclonal antibody fluorescent polarization immunoassay for cyclosporin. Transplant Proc 1990; 22: 1186–8.

Yatscoff RW Copeland KR Faraci CJ . Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporin in whole blood. Clin Chem 1990; 36: 1969–73.

Rogers LC Smith FA Jamero A . Evaluation of the Abbott TDx monoclonal cyclosporin A assay in paediatric cardiac transplant patients. Clin Chem 1991; 37: 1014.

Kyne F Maguire S O'Broin S McGing P Wright E . Abbott TDx selective assay overestimates cyclosporin in whole blood. Clin Chem 1991; 37: 1658.

Winkler M Schumann G Petersen D Oellerich M Wonigeit K . Monoclonal fluorescence polarization immunoassay evaluated for monitoring cyclosporin in whole blood after kidney, heart and liver transplantation. Clin Chem 1992; 38: 123–6.

Fuller KA Brown WS Koenig JW Eveland BJ Scott MG . Specific measurement of cyclosporin concentrations in whole blood: Radioimmunoassay and fluorescence polarization immunoassay compared. Clin Chem 1991; 37: 2150–2.

Syva EMIT®. Package Insert. Issue 6R004UL.1E. Palo Alto, CA: Syva Company, August 1991.

Dasgupta A Saldana S Desai M . Analytical performance of EMIT cyclosporin assay evaluated. Clin Chem 1991; 37: 2130–3.

Rosano T Brooks C Dybas M . EMIT monoclonal antibody assay evaluated for cyclosporin monitoring in whole blood. Clin Chem 1991; 37: 989.

Dusci LJ Hackett LP Chiswell GM Ilett KF . Comparison of cyclosporine measurement in whole blood by high-performance liquid chromatography, monoclonal fluorescence polarization immunoassay and monoclonal enzyme-multiplied immunoassay. Ther Drug Monit 1992; 14: 327–32.

Schumann G Petersen D Hoyer PF Wonigeit K . Monitoring cyclosporin A (ciclosporin, INN) concentrations in whole blood: Evaluation of EMIT™ assay in comparison with HPLC and RIA. Eur J Clin Chem Clin Biochem 1993; 31: 381–8.

McBride JH Kim SS Rodgerson DO Reyes AF Ota MK . Measurement of cyclosporine by liquid chromatography and three radioimmunoassays in blood from liver, cardiac and renal transplant recipients. Clin Chem 1992; 38: 2300–6.

Johnston A Marsden JT Holt DW . The United Kingdom cyclosporin quality assessment scheme. Ther Drug Monit 1986; 8: 200–4.

Johnston A Cullen G Holt DW . Quality assurance for cyclosporin assays in body fluids. Ann Acad Med Singapore 1991; 20: 3–8.

Holt DW Marwaha G Jones K Johnston A . Quality assurance programmes for immunosuppressive drugs. Cyclosporine and beyond. Ther Drug Monit 1993; 15: 472–7.

Calne R Rolles K White DJ Thiru S Evans DB Henderson R Cyclosporin A in clinical renal allografting. Transplant Proc 1981; 13: 349.

Thiel G . The use of cyclosporin blood level measurements in renal transplantation. In: Cyclosporin Issues of Today, Proceedings of the Wishaw Workshop, May 1986. Frimley: Sandoz Pharmaceuticals Ltd., 1986: 12–19.

Slapak M Georghegan T Digard N Ahmed K Sharman VL Crockett R . The use of low-dose cyclosporin A in combination with azathioprine and steroids in renal transplantation. Transplant Proc 1985; 17: 1222–5.

Fries D Kechrid C Charpentier B Hammouche M Moulin B Rieu P A prospective study of a triple association: Cyclosporine, corticosteroids and azathioprine in immunologically high-risk renal transplant. Transplant Proc 1985; 15: 1231–4.

Salaman JR . Cyclosporin monotherapy—who needs it? Clinical and Experimental Perspectives in Sandimmun Therapy Vol 1. London: Current Medical Literature Ltd., 1991: 1–4.

Feutren G . The optimal use of cyclosporin A in autoimmune diseases. J Autoimmun 1992; 5(suppl A): 183–95.

Kahan BD Grevel J . Overview: Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 1988; 46: 631–44.

Phillips TM Karmi SA Frantz SC Henriques HF . Absorption profiles of renal allograft recipients receiving oral doses of cyclosporine: A pharmacokinetic study. Transplant Proc 1988; 20(suppl 2): 457–61.

Grevel J Napoli KL Kahan BD . Steady state concentrations of cyclosporine for therapeutic monitoring. Transplant Proc 1990; 22: 1339–42.

Awni W Heim-Duthoy K Kasiske BL . Monitoring of cyclosporine by serial post-transplant pharmacokinetic studies in renal transplant patients. Transplant Proc 1990; 22: 1343–4.

Kahan BD Welsh M Rutzky L Lewis R Knight R Katz S The ability of pre-transplant test-dose pharmacokinetic profiles to reduce early adverse events after renal transplantation. Transplantation 1992; 53: 345–51.

Lindholm A Welsh M Rutsky L Kahan BD . The adverse impact of high cyclosporine clearance rates on the incidence of acute rejection and graft loss. Transplantation 1993; 55: 985–93.

Johnston A Sketris I Marsden JT Galustian CG Fashola T Taube D A limited sampling strategy for the measurement of cyclosporine AUC. Transplant Proc 1990; 22: 1345–6.

Cantarovich F Bizollon C Cantarovich D Lefrancois N Dubernard JM Traeger J . Cyclosporine plasma levels six hours after oral administration: A useful tool for monitoring therapy. Transplantation 1988; 45: 389–94.

Wallwork J . Cyclosporin: Issues of Today. Oxford: Medical Education Services Ltd., and Frimley: Sandoz Pharmaceuticals Ltd, 1986: 39–44.

Holt DW Johnston A . Cyclosporin monitoring: Its role in autoimmune indications. J Autoimmunity 1992; 5(suppl A): 177–82.

Trull AK Best NG Tan KKC Hue KL Higenbottam TW Large S Blood cyclosporin concentrations, but not doses, correlate with acute changes in renal function following heart and heart-lung transplantation. Ther Drug Monit 1992; 14: 275–80.

Hakim M Siegelhalter D English TAH Caine N Wallwork J . Cardiac transplantation with cyclosporine and steroids: Medium and long-term results. Transplant Proc 1988; 20(suppl 3): 327–32.

Lewis RM Van Buren CT Kerman RH . A review of long-term cyclosporine use in renal transplantation. Clin Transplant 1990; 4: 313–20.

Scott JP Higgenbottam TW Clelland CA Stewart S Smyth RL Otulana BA The natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9: 510–15.

Best NG Hue KL Trull AK Tan KKC Hue KL Spiegelhalter DJ Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation. Br J Clin Pharmacol 1992; 34: 513–20.

Tan KKC Hue KL Strickland SE Trull AK Smyth RL Scott JP Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis. Ther Drug Monit 1990; 12: 520–4.

Takaya S Zaghoul I Iwatsuki S Starzl TE Noguchi T Ohmori Y Effect of liver dysfunction on cyclosporine pharmacokinetics. Transplant Proc 1987; 19: 1246–7.

Venkataramanan R Starzl TE Yang S Burckart GJ Ptachcinski RJ Shaw BW Biliary excretion of cyclosporine in liver transplant patients. Transplant Proc 1985; 17: 286–9.

Whitington PF Emond JC Whitington SH Broelsch CE Baker AL . Small-bowel length and the dose of cyclosporine in children after liver transplantation. N Engl J Med 1990; 322: 733–8.

Adams DH Ponsford S Gunson B Boon A Honigsberger L Williams A Neurological complications following liver transplantation. Lancet 1987; i: 949–51.

Kahan BD . Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation 1985; 40: 457–76.

Ringdén O . Cyclosporine in allogeneic bone marrow transplantation. Transplantation 1986; 42: 445–52.

Atkinson K Downs K Ashby M Biggs J . Clinical correlations with cyclosporine blood levels after allogeneic bone marrow transplantation: An analysis of four different assays. Transplant Proc 1990; 22: 1331–4.

McGuire TR Yee GC Emerson S Gmur DJ Carlin J . Pharmacodynamic studies of cyclosporine in marrow transplant recipients. Transplantation 1992; 53: 1272–5.

Hunter AE Bessell EM Russell NH . Effective prevention of acute GVHD following allogeneic BMT with low leukaemic relapse using methotrexate and therapeutically monitored levels of cyclosporin A. Bone Marrow Transplant 1992; 10: 431–4.

Duraj FF Bäckman L Dati F Ringdén O . Serum levels of alpha-1-microglobulin and beta-2-microglobulin in bone marrow transplant recipients treated with cyclosporin A. Transpl Int 1991; 4: 146–50.

Soto J Alsar MJ Avendano C Sacristan JA Zubizarreta A . Comparison of cyclosporine levels in samples obtained from central venous catheter with samples from peripheral sites in allogeneic bone marrow transplantation: Implications in therapeutic monitoring of cyclosporine. Clin Transplant 1992; 6: 357–60.

Bach JF . Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity. J Autoimmun 1992; 5 (suppl A): 3–10.

Faulds D Goa KL Benfield P . Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drug 1993; 45: 953–1040.

Mockli G Kabra PM Kurtz TW . Laboratory monitoring of cyclosporine levels: Guidelines for the dermatologist. J Am Acad Dermatol 1990; 23: 1275–9.

Feutren G von Graffenried B . Pharmacology of cyclosporin A (Sandimmun®) and clinical experience in inflammatory bowel diseases. Schweiz Med Wschr 1991; 121: 748–53.

Feutren G . The optimal use of cyclosporin in autoimmune diseases. J Autoimmun 1992; 5(suppl A): 183–95.

First MR . Transplantation in the nineties. Transplantation 1992; 53: 1–11.